Literature DB >> 7587869

"Cercariform" cells: a clue to the cytodiagnosis of transitional cell origin of metastatic neoplasms?

C N Powers1, A Elbadawi.   

Abstract

The "cercariform" cell is described as a distinct cytomorphologic clue that may be helpful in the diagnosis of metastatic transitional cell neoplasms, particularly low grade. This cell has a nucleated globular body and a cytoplasmic process with a nontapering, flattened, bulbous or fishtail-like end. The cercariform cell corresponds to intermediate cells in histologic and ultrastructural preparations of normal urothelium. The cercariform appearance is the result of pseudostratification of both normal and low-grade neoplastic urothelium. The unique features of cercariform cells make them readily distinguishable from neoplastic squamous cells as well as spindle cells of mesenchymal origin.

Entities:  

Mesh:

Year:  1995        PMID: 7587869     DOI: 10.1002/dc.2840130105

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  Fine needle aspiration cytology of metastatic urothelial carcinoma: Study of seven cases with review of literature.

Authors:  Gagandeep Kaur; Pooja Bakshi; Kusum Verma
Journal:  J Cytol       Date:  2012-04       Impact factor: 1.000

Review 2.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

3.  Penile metastasis of urothelial carcinoma diagnosed by fine-needle aspiration.

Authors:  Gilda da Cunha Santos; Marcia Lanzoni de Alvarenga; Vinicius Freitas Borlot; Michel Antonio Kiyota Moutinho; Marcello Fabiano de Franco
Journal:  Cytojournal       Date:  2009-06-18       Impact factor: 2.091

4.  Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature.

Authors:  ÇiĞdem Vural; Kürsat Yildiz; Devrim Çabuk; Asli Akgül
Journal:  J Cytol       Date:  2015 Apr-Jun       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.